JP2003510243A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510243A5
JP2003510243A5 JP2000517725A JP2000517725A JP2003510243A5 JP 2003510243 A5 JP2003510243 A5 JP 2003510243A5 JP 2000517725 A JP2000517725 A JP 2000517725A JP 2000517725 A JP2000517725 A JP 2000517725A JP 2003510243 A5 JP2003510243 A5 JP 2003510243A5
Authority
JP
Japan
Prior art keywords
iodide
iodate
composition according
anion
aqueous composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000517725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510243A (ja
JP4187410B2 (ja
Filing date
Publication date
Priority claimed from US08/960,149 external-priority patent/US5885592A/en
Application filed filed Critical
Publication of JP2003510243A publication Critical patent/JP2003510243A/ja
Publication of JP2003510243A5 publication Critical patent/JP2003510243A5/ja
Application granted granted Critical
Publication of JP4187410B2 publication Critical patent/JP4187410B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000517725A 1997-10-29 1998-10-27 分子ヨウ素経口投与のための方法および医薬組成物 Expired - Fee Related JP4187410B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US960149 1997-10-29
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (3)

Publication Number Publication Date
JP2003510243A JP2003510243A (ja) 2003-03-18
JP2003510243A5 true JP2003510243A5 (cg-RX-API-DMAC7.html) 2005-05-26
JP4187410B2 JP4187410B2 (ja) 2008-11-26

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000517725A Expired - Fee Related JP4187410B2 (ja) 1997-10-29 1998-10-27 分子ヨウ素経口投与のための方法および医薬組成物

Country Status (17)

Country Link
US (1) US5885592A (cg-RX-API-DMAC7.html)
EP (1) EP1024815B1 (cg-RX-API-DMAC7.html)
JP (1) JP4187410B2 (cg-RX-API-DMAC7.html)
KR (1) KR100412219B1 (cg-RX-API-DMAC7.html)
CN (1) CN1150904C (cg-RX-API-DMAC7.html)
AT (1) ATE231725T1 (cg-RX-API-DMAC7.html)
AU (1) AU750627B2 (cg-RX-API-DMAC7.html)
BR (1) BR9812588A (cg-RX-API-DMAC7.html)
CA (1) CA2301503C (cg-RX-API-DMAC7.html)
DE (1) DE69811105T2 (cg-RX-API-DMAC7.html)
DK (1) DK1024815T3 (cg-RX-API-DMAC7.html)
ES (1) ES2191973T3 (cg-RX-API-DMAC7.html)
IL (1) IL134778A0 (cg-RX-API-DMAC7.html)
NO (1) NO20001673L (cg-RX-API-DMAC7.html)
PT (1) PT1024815E (cg-RX-API-DMAC7.html)
RU (1) RU2213564C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999021567A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
CA2317587A1 (en) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Solid iodophor preparations and process for producing the same
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
ATE497351T1 (de) * 2003-06-20 2011-02-15 Hills Pet Nutrition Inc Verfahren für die schilddrüsenüberfunktion bei der katze sowie zusammensetzungen mit eingeschränktem jodgehalt
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
JP5356831B2 (ja) * 2006-01-26 2013-12-04 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ科動物の甲状腺機能亢進症を治療するための方法及び組成物
CN101489411A (zh) * 2006-05-12 2009-07-22 希尔氏宠物营养品公司 用于预防或治疗具有甲状腺机能亢进的猫科动物的慢性肾衰竭的组合物和方法
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CA2656608C (en) * 2006-07-03 2014-09-16 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
US20140072598A1 (en) * 2011-05-16 2014-03-13 Shokan Sabirkhanovich Begaliev Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技(潍坊)有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
WO2015120458A1 (en) * 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
SG11201607686VA (en) 2014-03-31 2016-10-28 Iotech International Inc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
CA3031447A1 (en) 2016-07-21 2018-01-25 Iogen, Llc Emollient topical disinfectants
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
BR112023001995A2 (pt) 2020-08-13 2023-02-28 I2Pure Corp Composições de alta concentração de iodo molecular, formulações farmacêuticas, preparação e usos
US20240350534A1 (en) * 2020-12-12 2024-10-24 Iocure, Inc. Iodine delivery compounds
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Similar Documents

Publication Publication Date Title
RU2000107852A (ru) Фармацевтические составы для перорального введения молекулярного йода
JP3683582B2 (ja) 安定性、摂取可能及び吸収性のnadh及びnadph治療組成物
AU653026B2 (en) Physiologically active polypeptide-containing pharmaceutical composition
US5047398A (en) DDAVP antidiuretic and method therefor
AU4965497A (en) Tablet composition
CZ296221B6 (cs) Farmaceutický prostredek ve forme sumivé tablety,zahrnující aktivní slozku a efervescentní pár
CO4700482A1 (es) Formulaciones de un analogo monomero de insulina
KR970706830A (ko) 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2'-dithio-bis (ethanesulfonate) (dimesna)
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
IL96365A (en) Preparation for the treatment of inflammatory bowel disorders with C6-2 alkanoic acids
WO1997048382A3 (en) Multiple-unit type prolonged action drug preparation
TW344662B (en) A process for preparing a freeze dried thiotepa composition
IE42793B1 (en) Preparation for treatment of colitis
Semple et al. Role of bile acids in the pathogenesis of aspirin-induced gastric mucosal hemorrhage in rats
CA2270004A1 (en) Stable mitoxantrone solutions
JPS61172821A (ja) 医療用途を有する新規なヘミン錯化合物を製造する方法
GB1582162A (en) Stable prostaglandin composition and process for the preparation thereof
Reichl et al. Effect of glucose in mice after acute experimental poisoning with arsenic trioxide (As2O3)
Davies Paraquat poisoning: the rationale for current treatment regimes
US20170304359A1 (en) Oral iodine dosage form
GR3036481T3 (en) Medicament containing delta-aminolevulinic acid
ES2215025T3 (es) Formulacion farmaceutica efervescente, que contiene metamizol.
CN1957938B (zh) 一种葡醛内酯泡腾片及制备方法
Cleland et al. Angiotensin converting enzyme inhibition in heart failure.
CA2007387A1 (en) Bowel lavage composition